• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Simultaneous determinations of liver- and bone-type alkaline phosphatase by curve-fitting of inhibition kinetic data. I. Development and evaluation of an absorbance-based method.

作者信息

Fitzpatrick C P, Pardue H L

机构信息

Department of Chemistry, Purdue University, West Lafayette, IN 47907-1393.

出版信息

Clin Chem. 1992 Feb;38(2):238-46.

PMID:1541007
Abstract

We describe an approach for the simultaneous determination of isoenzymes of alkaline phosphatase (EC 3.1.3.1) based on the kinetic behavior of inhibition reactions. Data for absorbance vs time, collected while enzymes are being inhibited, are fitted with suitable models to obtain results related to activities of the individual isoenzymes. The primary focus is on two-component mixtures of the bone and liver isoenzymes of alkaline phosphatase, but some results are reported for three- and four-component mixtures. Factors studied include choices of inhibitors, buffers, pH, ionic strength, substrate concentration, kinetic models, data ranges, data densities, and data-processing approaches and programs. Criteria used to select optimal conditions include measurement times, detection limits, useful range, and agreement between expected and computed results for mixtures of isoenzymes. For two-component mixtures, a linear least-squares fit of isoenzyme content computed with the curve-fitting method (y) v a comparison method (x) gave y = 0.96 (+/- 0.05)x + 3.8 (+/- 3)% with r = 0.97 and standard error of the estimate of 9.4% for a range from 15 to 300 U/L. The pooled relative standard deviation (CV) for results was about 5%. Results were degraded for three- and four-component samples.

摘要

相似文献

1
Simultaneous determinations of liver- and bone-type alkaline phosphatase by curve-fitting of inhibition kinetic data. I. Development and evaluation of an absorbance-based method.
Clin Chem. 1992 Feb;38(2):238-46.
2
Simultaneous determinations of liver- and bone-type alkaline phosphatase by curve-fitting of inhibition kinetic data. II. Development and evaluation of a fluorescence-based method.
Clin Chem. 1992 Feb;38(2):247-55.
3
Differential theophylline inhibition of alkaline phosphatase and 5'-nucleotidase of bovine milk fat globule membranes.
Int J Biochem. 1991;23(7-8):743-7. doi: 10.1016/0020-711x(91)90047-q.
4
Multicomponent analysis for alkaline phosphatase isoenzyme determination by multiple linear regression.通过多元线性回归进行碱性磷酸酶同工酶测定的多组分分析。
Clin Chem. 1994 May;40(5):803-10.
5
Influence of inorganic phosphate on the activity determination of isoenzymes of alkaline phosphatase in various buffer systems.
Clin Chim Acta. 1980 Mar 28;102(2-3):215-9. doi: 10.1016/0009-8981(80)90035-2.
6
[Kinetic method for determination of isoenzymes of alkaline phosphatase in human blood serum].[人血清碱性磷酸酶同工酶测定的动力学方法]
Vopr Med Khim. 1983 Sep-Oct;29(5):43-8.
7
Error estimation in the quantification of alkaline phosphatase isoenzymes by selective inhibition methods.
Clin Chem. 1988 Dec;34(12):2490-3.
8
Quantitative method for determining serum alkaline phosphatase isoenzyme activity I. Guanidine hydrochloride: new reagent for selectively inhibiting major serum isoenzymes of alkaline phosphatase.血清碱性磷酸酶同工酶活性测定的定量方法I. 盐酸胍:选择性抑制血清碱性磷酸酶主要同工酶的新试剂。
J Clin Pathol. 1986 Sep;39(9):1025-30. doi: 10.1136/jcp.39.9.1025.
9
Chemical inhibition method for alkaline phosphatase isoenzymes in human serum.人血清碱性磷酸酶同工酶的化学抑制法
Am J Clin Pathol. 1975 Apr;63(4):564-72. doi: 10.1093/ajcp/63.4.564.
10
Serum alkaline phosphatases. Effect of pH and buffer on optimum substrate concentration.血清碱性磷酸酶。pH值和缓冲液对最佳底物浓度的影响。
Clin Chim Acta. 1973 May 18;45(3):287-91. doi: 10.1016/0009-8981(73)90440-3.